ClinicalTrials.gov record
Completed Phase 3 Interventional

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

ClinicalTrials.gov ID: NCT00331188

Public ClinicalTrials.gov record NCT00331188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension

Study identification

NCT ID
NCT00331188
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Debiovision
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

  • Sanvar® (vapreotide) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
May 31, 2008
Completion
Jun 30, 2008
Last update posted
Jul 7, 2008

2006 – 2008

United States locations

U.S. sites
19
U.S. states
17
U.S. cities
18
Facility City State ZIP Site status
UAB Liver Center Birmingham Alabama 35294-0005
Alabama Liver & Digestive Specialists Montgomery Alabama 36116
Mayo Clinic Scottsdale Arizona 85054
University of California at San Diego San Diego California 92103-8707
University of Colorado Health Sciences Center Denver Colorado 80262
Yale University School of Medicine New Haven Connecticut 06520
Mayo Clinic Jacksonville Florida 32224
Northwestern University, The Feinberg School of Medicine Chicago Illinois 60611
Indiana University School of Medicine Indianapolis Indiana 46202
University of Kentucky Medical Center Lexington Kentucky 40536
Johns Hopkins Hospital & School of Medicine, Div. of Gastroenterology & Hepatology Baltimore Maryland 21205
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Washington University School of Medicine St Louis Missouri 63110
Weill Medical College of Cornell University New York New York 10021
Columbia University Medical Center New York New York 10032
Mission Hospitals, Inc. Asheville North Carolina 28801
Medical University of South Carolina Charleston South Carolina 29425
CHRISTUS Santa Rosa Medical Center San Antonio Texas 78229
Virginia Commonwealth University MCV Campus West Hospital Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00331188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2008 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00331188 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →